top of page
News & Events
Aug 17, 2021
BrainsWay Hosting Key Opinion Leader Webinar on its Deep TMS™ Therapy for Treating Mental Health Dis
BrainsWay Hosting Key Opinion Leader Webinar on its Deep TMS™ Therapy for Treating Mental Health Disorders BURLINGTON, MA. and JERUSALEM,...
Aug 16, 2021
Living with O.C.D. in a Pandemic
Highlights include treatment methods for OCD, emphasizing noninvasive techniques such as TMS as a valuable and effective treatment...
Aug 11, 2021
BrainsWay Reports Second Quarter 2021 Financial Results and Operational Highlights
Strong Revenue Growth of 45% Year-over-Year in Q2 2021 Gained Meaningful Traction in Reimbursement for Deep TMS™ in both OCD and...
Jul 30, 2021
Neurostimulation for Mental Health Disorders
Topics discussed in the interview include Christopher von Jako’s background; his inspiration as CEO of a game-changing mental health...
Jul 28, 2021
BrainsWay to Report Second Quarter 2021 Financial Results on August 11, 2021
CRESSKILL, N.J. and JERUSALEM, July 28, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a...
Jul 26, 2021
CW Focus Atlanta – Deep TMS™
Mental health advocate Buffie Purselle of Rejuvenate TMS recently appeared on CW’s Focus Atlanta, where she shared her battle with severe...
Jul 12, 2021
Active Recovery TMS: Treating obsessive-compulsive disorder
Dr. Prithan Raj, Chief Medical Officer (CMO) at Active Recovery TMS discusses how his clinic treats obsessive-compulsive disorder (OCD)....
Jul 9, 2021
Evaluating Transcranial Magnetic Stimulation Technologies: Deep vs. Traditional
Dr. Rodriguez discusses the differences between Deep TMS vs. Traditional TMS, highlighting how Deep TMS is clinically proven to stimulate...
Jul 6, 2021
BrainsWay to Present at the Ladenburg Thalmann 2021 Healthcare Conference
CRESSKILL, N.J. and JERUSALEM, Israel, July 6, 2021 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...
Jun 11, 2021
Centene Goes “Sci-Fi” with new Brain Treatment
Highlights around the partnership between BrainsWay and Centene regarding Deep TMS™ coverage, with commentary from CEO Christopher von...
Jun 8, 2021
BrainsWay to Present at the Raymond James Human Health Innovation Conference
CRESSKILL, N.J. and JERUSALEM, June 08, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a...
Jun 7, 2021
BrainsWay to Present at Clinical TMS Society Annual Meeting and Psych Congress Elevate
CRESSKILL, N.J. and JERUSALEM, Israel, June 7, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the...
Jun 2, 2021
BrainsWay Announces Positive OCD Coverage Policy by Blue Cross Blue Shield® Licensee HCSC
HCSC Covers Approximately 17 Million Members Across Five States CRESSKILL, N.J. and JERUSALEM, Israel, June 2, 2021 (GLOBE NEWSWIRE) –...
Jun 1, 2021
BrainsWay Announces First Draft Proposal for OCD Coverage by a Regional Medicare Administrative Cont
BrainsWay Announces First Draft Proposal for OCD Coverage by a Regional Medicare Administrative Contractor Palmetto GBA, Administrator of...
May 26, 2021
6 Ways to Leverage Emotional Intelligence As a Leader
BrainsWay CEO and President Christopher von Jako discusses how emotional intelligence aided in the many milestones and achievements that...
May 24, 2021
BrainsWay Announces First of its Kind Positive Coverage Policy by Centene for the Treatment of OCD U
BrainsWay Announces First of its Kind Positive Coverage Policy by Centene for the Treatment of OCD Utilizing Deep TMS™ CRESSKILL, N.J....
May 20, 2021
BrainsWay Reports First Quarter 2021 Financial Results and Operational Highlights
*Note, the numbers contained herein reflect certain updates to the previous unaudited financial results for the first Quarter 2021,...
May 19, 2021
BrainsWay to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
CRESSKILL, N.J. and JERUSALEM, May 19, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a...
bottom of page